(Q33933478)

30 July 2017

title

Role of pharmacokinetics in the discovery and development of indinavir (English)

1 reference

30 July 2017

1 reference

1 reference

Lin JH

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Advanced Drug Delivery Reviews

30 July 2017

published in

1 reference

30 July 2017

volume

39

1 reference

30 July 2017

issue

1-3

1 reference

30 July 2017

page(s)

33-49

1 reference

HIV protease: a novel chemotherapeutic target for AIDS.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

HIV protease as an inhibitor target for the treatment of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Rational design of peptide-based HIV proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Structure-based inhibitors of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

L-687,908, a potent hydroxyethylene-containing HIV protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

L-735,524: the design of a potent and orally bioavailable HIV protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Effect of viscosity of test meals on gastric emptying in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Stimulation of gastric acid secretion by dimaprit in unanesthetized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological data

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Transport and Binding of Methotrexate In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

In vitro methods for assessing human hepatic drug metabolism: their use in drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

ABC Transporters: From Microorganisms to Man

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

HIV-1 protease inhibitors and the MDR1 multidrug transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine*

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

First-pass metabolism of midazolam by the human intestine.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

Time and dose dependence of 3-methylcholanthrene-induced metabolism in rat intestinal mucosal cells and microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900018-6

7 January 2021

10.1016/S0169-409X(99)00018-6

Identifiers

DOI

1 reference

30 July 2017

1 reference